Endosense, a Geneva-based medical technology company, has named Nicolas Marsault as its new CFO. Marsault has previously worked in a variety of managerial positions at Merck Serono. He replaces Endosense’s previous chief financial officer, Andrea Buscaglia.
You are browsing the archive for Merck Serono - peHUB.
Auxogyn, the women’s reproductive health company based in Menlo Park, California, just raised $18 million in a Series B round led by SR One. All of its Series A investors, including Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures, participated in the funding. Simeon George, from SR One, and Nilesh Kumar, of [...]
Merck Serono, a division of Merck KGaA, has formed a corporate venture capital group that will invest in biotech startups. Named Merck Serono Ventures, the effort is initially capitalized with €40 million. Areas of particular interest include neurodegenerative diseases, oncology, autoimmune diseases and inflammatory diseases.